Association among lifestyle status and dyslipidemia in Yasuj

Subject Areas : Journal of Physical Activity and Hormones

Masoud Yari ¹ , Mehrzad Moghadasi ² , Seyed Ali Hosseini ³ , Rahim Shirazi-nezhad ⁴

1 - Department of Exercise physiology, Yasuj branch, Islamic Azad University, Yasuj, Iran
2 - Department of Exercise physiology, Shiraz branch, Islamic Azad University, Shiraz, Iran
3 - Department of Exercise physiology, Marvdasht branch, Islamic Azad University, Marvdasht, Iran
4 - Department of Exercise physiology, Shiraz branch, Islamic Azad University, Shiraz, Iran

Received: 2017-03-15 Accepted : 2017-05-29 Published : 2017-06-23

Keywords:

References:

1. Jamison DT, Feachem RG, Makgoba MW, Bos ER, Baingana FK, Hofman KJ, et al. Disease and Mortality in Sub-Saharan Africa, 2^nd Edition, Washington (DC): World Bank; 2006.

2. The Six Report of the Joint National Committee on Prevention, Detection, Evolution, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.

3. Steinhagen TE, Bramlage P, Lösch C, Hauner H, Schunkert H, Vogt A, et al. Dyslipidemia in primary care prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovascular Diabetol 2008; 7: 1-11.

4. Kimiagar M, Ghaffarpour M, Houshiar-Rad A, Hormozdyari H, Zellipour L. Food consumption pattern in the Islamic Republic of Iran and its relation to coronary heart disease. East Mediterr Health J 1998; 4: 539-547.

5. Moghadasi M, Nouri R, Moraveji F, Nematollahzadeh M, Javanmardi R. Association among lifestyle status and dyslipidemia in Shiraz adults. Med dello Sport 2013; 66: 81-89

6. Onat A, Surdum-Avci G, Senocak M, Ornek E, Gözükara Y. Plasma lipids and their interrelationship in Turkish adults. J Epidemiol Community health 1992; 46: 470-476.

7. Maclean DR, Petrasovits A, Connelly PW, Joffres M, O'connor B, Little JA. Plasma lipids and lipoprotein reference values and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health surveys Research Group. Canadian J Cardiol 1996; 15: 434-444.

8. Phillips NR, Havel RJ, Kane JP. Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides: association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis 1981; 1: 13-24.

9. Neville JN. On matters of the heart: past, present and future. J Am Diet Ass 1990; 90: 211-213.

10. Stähelin HB, Eichholzer M, Gey KF. Nutritional factors correlating with cardiovascular disease: results of the Basel Study. Bibliotheca Nutr Diet 1992; 49: 24-35.

11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Grundy SM, Chairman). The second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994; 89: 1329-1445.

12. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic Syndrome, Obesity, and Mortality: Impact of cardiorespiratory fitness. Diabetes Care 2005; 28: 391-397.

13. Belloc NB, Breslow L. Relationship of physical health status and health practices. Prev Med 1972; 1: 409-421.

14. Soori H. Pattern of dietary behaviour and obesity in Ahwaz, Islamic Republic of Iran. East Mediterr Health J 2001; 7: 163-170.

15. Moghadasi M, Nikbakht M, Kuchaki M. Lifestyle status, food consumption pattern and it's relation to dyslipidemia. Braz J Biom 2010; 4: 165-173.

16. Posner BM, Quatromoni PA, Franz M. Nutrition policies and interventions for chronic disease risk reduction in international settings: the INTER-HEALTH nutrition initiative. Nutr Rev 1994; 52: 179-187.

17. Department of Health. Nutritional aspects of cardiovascular disease: report of the cardiovascular review group committee on medical aspects of food policy. London, Her Majesty's Stationery Office, (Report on health and social subjects: 1994.

18. Shetty PS, Mcpherson K. Diet, nutrition and chronic disease: lessons from contrasting worlds. Chichester, Wiley: 1997.

19. Sjöström L, Närbro K, Sjöström D. Costs and benefits when treating obesity. Int J Obes Relat Metab Disord 1995; 19: S9-12.

20. Dreon DM, Frey-Hewitt B, Ellsworth PT, Williams RB, Wood PD. Dietary fat: carbohydrate ratio and obesity in middle-aged men. Am J Clin Nutr 1988; 47: 995-1000.

21. Mohebbi H, Moghadasi M, Rahmani-Nia F, Hassan-Nia S, Noroozi H. Association among lifestyle status, plasma adiponectin level and metabolic syndrome in obese middle aged men. Braz J Biom 2009; 3: 243-252.

22. Franz MJ. Metabolic syndrome: Lifestyle intervention in its prevention, treatment and mitigation. Health Connections 2008; 5: 1-2.

23. Janiszewski PM, Saunders TJ, Ross R. Themed Review: Lifestyle treatment of the metabolic syndrome. Am J Life Med 2008; 2: 99-108.

24. Cortez-Pinto H, Machado M. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 2008; 2: 217-231.

25. Nikkila EA, Taskinen MR, Rehunen S, Harkonen M. Lipoprotein lipase activities in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism 1978; 27: 1661-1671.

26. Umeda T, Kono S, Sakurai Shinchi K, Imanishi K, Nishikawa H, Ogawa S, et al. Relationship of cigarette smoking, alcohol use, recreational exercise and obesity with serum lipid atherogenicity: a study of self-defense officials in Japan. J Epidemiol 1998; 8: 227-234.

27. Hegarty KM, Turgiss LE, Mulligan JJ, Cluette JE, Kew RR, Stack DJ, et al. Effects of cigarette smoking on high density lipoprotein phospholipids. Biochem Biophys Res Commun 1982; 104: 212-219.

28. Criqui MH, Wallace RB, Heiss G, Mishkel M, Schonfeld G, Jones GT. Cigarette smoking and plasma high-density lipoprotein cholesterol: The Lipid Research Clinics Program Prevalence Study. Circulation 1980; 62: 70-76.